Urinalysis Market by Product (Consumables (Pregnancy & Fertility Kits, Dipsticks, Disposable, Reagents), Instruments (Automated, Semi-automated, PoC Analyzers)), Test Type (Biochemical, Sediment), Application (UTI, Diabetes) - Global Forecast to 2029

Urinalysis Market by Product (Consumables (Pregnancy & Fertility Kits, Dipsticks, Disposable, Reagents), Instruments (Automated, Semi-automated, PoC Analyzers)), Test Type (Biochemical, Sediment), Application (UTI, Diabetes) - Global Forecast to 2029

The urinalysis market is valued at an estimated USD 4.3 billion in 2024 and is projected to reach USD 6.8 billion by 2029 at a CAGR of 9.6% during the forecast period.

Due to rapid growth in the senior population, the prevalence of age-associated diseases such as diabetes and liver & kidney diseases is expected to increase significantly. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for the basic metabolic panel, lipid profile, and liver & renal panel tests. These tests are performed by urinalysis analyzers, thereby positively impacting market growth. The global rise in the geriatric population is considered a key factor in driving the growth of the urinalysis market.

“Consumables segment accounted for the highest growth rate in the urinalysis market, by product, during the forecast period.”

Based on product, the urinalysis market is bifurcated into consumables and instruments. The consumables segment in the urinalysis market is experiencing substantial growth. The recurrent requirement and purchase of these consumables is one of the primary reasons for the high growth rate of this market segment. Also, the wider range of consumables available in the market for urinalysis is contributing significantly to its larger share. The urinalysis market offers variety of consumables catering to different testing needs. Development of new dipsticks with more test parameters will further increase their demand in future.

“Disease screening segment accounted for the highest growth rate in the urinalysis market, by application, during the forecast period.”

The urinalysis market is bifurcated into disease screening and pregnancy & fertility testing. Disease screening segment is expected to account for the highest CAGR during the forecast period. As urinalysis plays an integral role in diagnosing such diseases, the urinalysis market for disease screening applications is expected to grow in the coming years. Additionally, many conditions detectable through urinalysis, such as early-stage kidney disease and diabetes, often do not exhibit symptoms until they are advanced. Regular urinalysis enables early detection and intervention, which can significantly improve patient outcomes and reduce long-term healthcare costs. This will bolster the extensive use of urinalysis in disease screening, ensuring its position as the largest segment in the market.

“Asia Pacific: The fastest-growing region in urinalysis market.”

The worldwide market for urinalysis is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific region is poised to experience the most notable CAGR within the urinalysis market. The high growth in the Asia Pacific can be attributed to the increasing government efforts to increase awareness about early disease detection, growing per capita income, the expansion of private-sector hospitals to rural areas in various Asia Pacific countries, and the presence of high-growth markets in the region.

The break-up of the profile of primary participants in the urinalysis market:

By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 – 30%

By Designation: C-level - 27%, D-level - 18%, and Others - 55%

By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa- 4%

The key players in this market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (US), Abbott (US), Danaher (US), Sysmex Corporation (Japan), Thermo Fisher Scientific Inc. (US), QuidelOrtho Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics Holdings plc (UK), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (US), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Co., Ltd. (China), DIRUI INDUSTRIAL CO., LTD. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), Erba Mannheim (UK), Alphatec Scientific E.I.R.L. (Peru), Teco Diagnostics (US), Analyticon Biotechnologies GmbH (Germany), Bioway Biological Technology Co., Ltd. (China), High Technology, Inc. (US), Agappe Diagnostics Ltd. (India), TOYOBO CO., LTD. (Japan), DIALAB GmbH (Austria), Quantimetrix (US), BioCare Corporation (Taiwan), Randox Laboratories Ltd. (Ireland), PZ Cormay S.A. (Poland), YD Diagnostics (South Korea), CONTEC MEDICAL SYSTEMS CO., LTD. (China), and Biopanda Reagents Ltd. (UK).

Research Coverage:

This research report categorizes the urinalysis market by product (Consumables [Pregnancy & Fertility Kits, Dipsticks, Disposables, Reagents], Instruments [Automated Urine Analyzers {Integrated Urine Analyzers, Sediment Urine Analyzers (Microscopy Analyzers, Flow Cytometry Analyzers), Biochemical Urine Analyzers, Semi-automated Urine Analyzers}, and Point-of-care Urine Analyzers], by test type (Pregnancy & Fertility Tests, Biochemical Tests [Laboratory Tests, PoC Tests], and Sediment Urinalysis), by application (Disease Screening [Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, and Other Disease Screening Applications] and Pregnancy & Fertility Testing), by end user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the urinalysis market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product launches and recent developments associated with the urinalysis market. Competitive analysis of upcoming startups in the urinalysis market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urinalysis market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer, rising geriatric population and subsequent increase in age-associated diseases, and increasing adoption of PoC urine diagnostic tests), opportunities (Growth opportunities in emerging countries, technological advancements in urine analyzers, and increasing government initiatives and funding for preventive care), restraints (Availability of refurbished urine analyzers and high capital investments and lack of skilled laboratory technicians), and challenges (Changing regulatory landscape) influencing the growth of the urinalysis market.

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urinalysis market.

Market Development: Comprehensive information about lucrative markets – the report analyses the urinalysis market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urinalysis market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (US), Abbott (US), and Danaher (US).